Literature DB >> 12361756

Cytomegalovirus mediated myelosuppression.

Julie Randolph-Habecker1, Mineo Iwata, Beverly Torok-Storb.   

Abstract

Cytomegalovirus (CMV) has long been associated with myelosuppression. Evidence for this association has been provided from in vitro studies, statistical analysis of clinical studies, informative case reports, and murine models. Reports differ as to how CMV mediates myelosuppression. Some data indicate direct infection of hematopoietic progenitors and their progeny, others indicate that the supportive microenvironment is infected and thereby its supportive function compromised. In this report we review data suggesting that the severity of myelosuppression in patients is associated with particular CMV genotypes identified by variations in the glycoprotein B gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361756     DOI: 10.1016/s1386-6532(02)00092-6

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

1.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

Authors:  Sergey V Smirnov; Ryhor Harbacheuski; Anita Lewis-Antes; Hua Zhu; Pranela Rameshwar; Sergei V Kotenko
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

2.  Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.

Authors:  Estibaliz Lazaro; Gaelle Coureau; Jérémie Guedj; Patrick Blanco; Isabelle Pellegrin; Daniel Commenges; François Dabis; Jean-François Moreau; Jean-Luc Pellegrin; Rodolphe Thiébaut
Journal:  Antivir Ther       Date:  2006

3.  Primary marrow-derived stromal cells: isolation and manipulation.

Authors:  Aravind Ramakrishnan; Beverly Torok-Storb; Manoj M Pillai
Journal:  Methods Mol Biol       Date:  2013

4.  The role of the marrow microenvironment in hematopoietic stem cell transplantation.

Authors:  Aravind Ramakrishnan; Beverly J Torok-Storb
Journal:  Cell Ther Transplant       Date:  2010-04-01

5.  Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes.

Authors:  Angela Capobianchi; Anna Paola Iori; Alessandra Micozzi; Giovanni Fernando Torelli; Anna Maria Testi; Corrado Girmenia; Stefania Santilli; Walter Barberi; Guido Antonelli; Robin Foà; Giuseppe Gentile
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

6.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

7.  Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study.

Authors:  Phaedon Zavras; Yiqi Su; Jiaqi Fang; Anat Stern; Nitasha Gupta; Yuexin Tang; Amit Raval; Sergio Giralt; Miguel Angel Perales; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  Biol Blood Marrow Transplant       Date:  2020-04-19       Impact factor: 5.742

8.  Reduced expression of gamma interferon in serum and marked lymphoid depletion induced by Porphyromonas gingivalis increase murine morbidity and mortality due to cytomegalovirus infection.

Authors:  Jacob Stern; Ela Shai; Batia Zaks; Amal Halabi; Yael Houri-Haddad; Lior Shapira; Aaron Palmon
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34+ Hematopoietic Progenitor Cells.

Authors:  Meaghan H Hancock; Lindsey B Crawford; Andrew H Pham; Jennifer Mitchell; Hillary M Struthers; Andrew D Yurochko; Patrizia Caposio; Jay A Nelson
Journal:  Cell Host Microbe       Date:  2019-12-19       Impact factor: 21.023

10.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.